Celcuity Inc at Needham Healthcare Conference (Virtual) Transcript
Thank you for joining me in the third day of the Needham & Company healthcare conference. My name is Gil Blum, and I'm a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today, Brian Sullivan, the Chairperson and CEO of Celcuity.
As a reminder, any viewers who are watching through our conference portal are able to submit questions via the ask-a-question box below the video feed window. And with that, Brian, you have the floor.
Great. Well, thank you, Gil. And thank you, all, for attending the conference and attending this presentation. What I'd like to do is just give you a little background on the company and how we got into drug development business and then review data and the study design of an ongoing Phase 3 study that we have.
Well, I started the company about 10 years ago with our Chief Science Officer, with the goal of developing a new cellular analysis platform. Essentially, we had developed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |